Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

New England Journal of Medicine - Tập 377 Số 5 - Trang 431-441 - 2017
Charles V. Pollack, Paul Reilly1, Joanne van Ryn2, John W. Eikelboom3, Stephan Glund2, Richard A. Bernstein4, Robert Dubiel1, Menno V. Huisman5, Elaine M. Hylek6, CW Kam7, Pieter W. Kamphuisen8, Jörg Kreuzer9, Jerrold H. Levy10, Gordon Royle11, Frank W. Sellke12, Joachim Stangier2, Thorsten Steiner13,14, Peter Verhamme15, Bushi Wang1, Laura Young16, Jeffrey I. Weitz3
1Boehringer Ingelheim, Ridgefield, CT
2Boehringer Ingelheim, Biberach
3McMaster University and the Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada;
4Feinberg School of Medicine, Northwestern University, Chicago
5Leiden University Medical Center, Leiden
6Boston University School of Medicine, Boston
7Tuen Mun Hospital, Hong Kong
8Tergooi Hospital, Hilversum
9Boehringer Ingelheim, Ingelheim am Rhein
10Duke University School of Medicine, Durham, NC
11Middlemore Hospital
12Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence
13Heidelberg University Hospital, Heidelberg
14Klinikum Frankfurt Höchst, Frankfurt
15KU Leuven, center for molecular and vascular biology, Leuven, Belgium
16University of Auckland

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1182/blood-2012-11-468207

10.1056/NEJMoa1502000

10.1160/TH15-03-0192

10.1016/j.jacc.2013.07.104

10.2165/00003088-200847050-00001

10.1097/MBC.0b013e32834f1b0c

10.1111/j.1538-7836.2009.03678.x

10.1056/NEJMoa0905561

10.1007/s40262-016-0417-0

10.1160/TH14-12-1080

10.1016/S1474-4422(16)00110-1

10.1182/blood-2016-08-731638

Mehta KD, 2016, Blood, 128, 1177, 10.1182/blood.V128.22.1177.1177

Heit JA, Blood

Sarode R, 2013, Circulation, 128, 1234, 10.1161/CIRCULATIONAHA.113.002283

10.1016/S0140-6736(14)61685-8

10.1056/NEJMoa1607887

10.1056/NEJMoa1607887

10.1093/europace/euv309

10.1007/s11239-017-1476-2

Thông tin
Thông tin xuất bản

New England Journal of Medicine

Tập 377 Số 5

431-441

Thông tin tác giả